Medifast Inc $ 102 0 (0%)
Volume:
154,364
Avg Vol (1m):
311,161
Market Cap $:
1.21 Bil
Enterprise Value $:
1.11 Bil
P/E (TTM):
17.34
P/B:
9.87
| Earnings Power Value | ||
| Net Current Asset Value | ||
| Tangible Book | ||
| Projected FCF | ||
| Median P/S Value | ||
| Graham Number | ||
| Peter Lynch Value | ||
|
Price: $102 | ||
Manual of Stocks™ Web
Financial Strength | 7/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 8.75 | ||
| Equity-to-Asset | 0.59 | ||
| Debt-to-Equity | 0.1 | ||
| Debt-to-EBITDA | 0.14 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 13.94 | ||
| Beneish M-Score | -2.15 | ||
| WACC vs ROIC | |||
Profitability | 8/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 14 | ||
| Net Margin % | 11.22 | ||
| ROE % | 62.59 | ||
| ROA % | 38.78 | ||
| ROC (Joel Greenblatt) % | 343.05 | ||
| 3-Year Revenue Growth Rate | 22.4 | ||
| 3-Year EBITDA Growth Rate | 27.1 | ||
| 3-Year EPS without NRI Growth Rate | 41.8 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 17.64 | ||
| Forward PE Ratio | 11.82 | ||
| PE Ratio without NRI | 17.64 | ||
| Price-to-Owner-Earnings | 20.72 | ||
| PB Ratio | 10.04 | ||
| PS Ratio | 1.94 | ||
| Price-to-Free-Cash-Flow | 21.13 | ||
| Price-to-Operating-Cash-Flow | 18.2 | ||
| EV-to-EBIT | 12.62 | ||
| EV-to-EBITDA | 12.09 | ||
| EV-to-Revenue | 1.72 | ||
| PEG Ratio | 1.59 | ||
| Shiller PE Ratio | 47.74 | ||
| Current Ratio | 2.26 | ||
| Quick Ratio | 1.62 | ||
| Days Inventory | 94.28 | ||
| Days Sales Outstanding | 0.56 | ||
| Days Payable | 172.23 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 2.89 | ||
| Dividend Payout Ratio | 0.46 | ||
| 3-Year Dividend Growth Rate | 106.1 | ||
| Forward Dividend Yield % | 2.94 | ||
| 5-Year Yield-on-Cost % | 2.96 | ||
| 3-Year Average Share Buyback Ratio | 0.2 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 10.05 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 2.02 | ||
| Price-to-Median-PS-Value | 1.36 | ||
| Price-to-Peter-Lynch-Fair-Value | 0.99 | ||
| Price-to-Graham-Number | 2.81 | ||
| Earnings Yield (Greenblatt) % | 7.96 | ||
| Forward Rate of Return (Yacktman) % | 20.99 |